148 related articles for article (PubMed ID: 23483670)
1. The role of Human papilloma virus (HPV) genotyping in recurrent respiratory papillomatosis in Rasoul Akram Hospital.
Izadi F; Hamkar R; Ghanbari H; Abdolmotallebi F; Jahandideh H
Med J Islam Repub Iran; 2012 May; 26(2):90-3. PubMed ID: 23483670
[TBL] [Abstract][Full Text] [Related]
2. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.
Wiatrak BJ; Wiatrak DW; Broker TR; Lewis L
Laryngoscope; 2004 Nov; 114(11 Pt 2 Suppl 104):1-23. PubMed ID: 15514560
[TBL] [Abstract][Full Text] [Related]
3. The role of HPV type in Recurrent Respiratory Papillomatosis.
Donne AJ; Hampson L; Homer JJ; Hampson IN
Int J Pediatr Otorhinolaryngol; 2010 Jan; 74(1):7-14. PubMed ID: 19800138
[TBL] [Abstract][Full Text] [Related]
4. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11.
Tjon Pian Gi RE; San Giorgi MR; Slagter-Menkema L; van Hemel BM; van der Laan BF; van den Heuvel ER; Dikkers FG; Schuuring EM
Head Neck; 2015 Nov; 37(11):1625-32. PubMed ID: 24955561
[TBL] [Abstract][Full Text] [Related]
6. Current and future management of recurrent respiratory papillomatosis.
Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
Laryngoscope Investig Otolaryngol; 2018 Feb; 3(1):22-34. PubMed ID: 29492465
[TBL] [Abstract][Full Text] [Related]
7. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso.
Ilboudo M; Zohoncon TM; Traore IMA; Traore EMA; Kande A; Obiri-Yeboah D; Djigma FW; Gyebre YMC; Simpore J
Am J Otolaryngol; 2019; 40(3):368-371. PubMed ID: 30799210
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment.
Szeps M; Dahlgren L; Aaltonen LM; Öhd J; Kanter-Lewenshon L; Dahlstrand H; Munck-Wikland E; Grandér D; Dalianis T
J Gen Virol; 2005 Jun; 86(Pt 6):1695-1702. PubMed ID: 15914847
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus (HPV) Genotype Distribution in Patients with Recurrent Respiratory Papillomatosis (RRP) in Iran.
Eftekhaar NS; Karbalaie Niya MH; Izadi F; Teaghinezhad-S S; Keyvani H
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1973-1976. PubMed ID: 28749631
[TBL] [Abstract][Full Text] [Related]
10. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
Go C; Schwartz MR; Donovan DT
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
[TBL] [Abstract][Full Text] [Related]
11. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
12. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
Durzyńska J; Błazejewska P; Szydłowski J; Goździcka-Józefiak A
Viral Immunol; 2010 Aug; 23(4):415-23. PubMed ID: 20712486
[TBL] [Abstract][Full Text] [Related]
13. In RRP, serologic response to HPV is frequently absent and slow to develop.
Buchinsky FJ; Ruszkay N; Valentino W; Derkay CS; McClay JE; Bastian RW; Myer CM; Lollar KW; Guris D
PLoS One; 2020; 15(3):e0230106. PubMed ID: 32160246
[TBL] [Abstract][Full Text] [Related]
14. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
Yiu Y; Fayson S; Smith H; Matrka L
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
[TBL] [Abstract][Full Text] [Related]
15. Factors Related to Extralaryngeal Spread in Juvenile Recurrent Respiratory Papillomatosis.
Labedz G; Scatolini ML; Ruvinsky S; Rodriguez HA
Laryngoscope; 2021 Jul; 131(7):1652-1656. PubMed ID: 33274778
[TBL] [Abstract][Full Text] [Related]
16. Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis.
Huebbers CU; Preuss SF; Kolligs J; Vent J; Stenner M; Wieland U; Silling S; Drebber U; Speel EJ; Klussmann JP
PLoS One; 2013; 8(2):e57207. PubMed ID: 23437342
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
[TBL] [Abstract][Full Text] [Related]
18. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
[TBL] [Abstract][Full Text] [Related]
19. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
[TBL] [Abstract][Full Text] [Related]
20. HPV Strain Predicts Severity of Juvenile-Onset Recurrent Respiratory Papillomatosis with Implications for Disease Screening.
Bedard MC; de Alarcon A; Kou YF; Lee D; Sestito A; Duggins AL; Brusadelli M; Lane A; Wikenheiser-Brokamp KA; Wells SI; Smith DF
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
